Clavis, Clovis expand cancer collaboration

Clavis Pharma ASA (OSE:CLAVIS) expanded a 2009 deal with Clovis Oncology Inc. (Boulder, Colo.) to give Clovis worldwide rights to pancreatic cancer candidate CP-4126 ( CO-101). Clovis previously had r...